BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28

• Policy

  U.S. FDA Accepts Biologics License Application (BLA) For Mylan And BioCon’s Proposed Biosimilar Pegfilgrastim For Review

  February 16, 2017

   · 

  7 min read
• Drug Development

  City of Hope To Manufacture NurOwn For BrainStorm Cell’s Phase III ALS Clinical Trial

  February 16, 2017

   · 

  4 min read
• Pharm Country

  Windtree Therapeutics Completes $10.5 Million Private Offering

  February 16, 2017

   · 

  3 min read
• Business

  Insmed To Host Fourth Quarter And Year-End 2016 Financial Results Conference Call On Thursday, February 23, 2017

  February 16, 2017

   · 

  1 min read
• Pharm Country

  Paradigm Diagnostics Banks $7 Million Series B Funding

  February 16, 2017

   · 

  3 min read
• Drug Development

  Amgen’s Repatha CVOT Results Are Potential Game-Changer For Lipid-Lowering Treatment

  February 16, 2017

   · 

  4 min read
• Genetown

  Glytec LLC Release: New Research Further Validates Benefits Of Personalized Diabetes Therapy Management Across The Continuum Of Care

  February 16, 2017

   · 

  6 min read
• Biotech Beach

  SoCal’s Avenu Medical Rakes in $13 Million

  February 16, 2017

   · 

  1 min read
• BioMidwest

  The New England Journal of Medicine Publishes Five-Year Data From Ethicon-Funded STAMPEDE Study

  February 16, 2017

   · 

  5 min read
• Drug Development

  Eli Lilly Release: Additional Results From Pivotal RA-BEAM Study Published In The New England Journal of Medicine Show Baricitinib-Treated Patients Demonstrated Sustained Improvement In Rheumatoid Arthritis Compared To Adalimumab And Placebo

  February 16, 2017

   · 

  9 min read